215 citations
,
March 2011 in “Clinical Cancer Research” This study found that sorafenib was active against desmoid tumors, with 25% of patients achieving a partial response and 70% maintaining stable disease.
4 citations
,
December 2024 in “JAAD Case Reports” This review discusses previously reported cases of drug-associated hidradenitis suppurativa linked to various immunomodulating medications but reports no new clinical results.
April 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” This study reports that 71% of patients treated with the gamma-secretase inhibitor PF-03084014 for desmoid tumors experienced dermatologic side effects, such as follicular lesions and pruritic eruptions, which were managed with topical or systemic treatments.
July 2025 in “JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH” In this case report, a nine-year-old boy with an unusual scalp nodule was found to have trichofolliculoma, a rare skin tumor, emphasizing the importance of considering this diagnosis in children and using dermoscopy and histopathology for accurate identification and treatment.
July 2022 in “International journal of surgery science” This case report details a rare large epidermal cyst over the sacrumcoccygeal region in an elderly patient, which was successfully removed surgically.